An unsolicited $1.6 million grant to the Bandim Health Project at the University of Southern Denmark (SDU) would randomly assign more than 14,000 newborns into two groups, those who would receive the vaccine at birth and those who would act as a control group with delayed vaccination. But we already know that Withholding vaccination will predictably result in an increased incidence of liver disease later in life, including liver failure, cirrhosis and cancer. Therefore, the true scale of the tragedy brought on by this study would never be fully be known.

Already patently unethical, the study design would also exploit one of the world’s poorest countries, where more than 50 percent of its population live in poverty, according to the World Bank. The Center for Infectious Disease Research and Policy of the University of Minnesota reports that about 1 in 5 people born in Guinea-Bissau has chronic hepatitis B, that 9 in 10 babies who are exposed at birth develop a chronic infection and that 1 out of 4 of them will die of hepatitis B-related liver disease.

There is a larger bizarre context surrounding this now paused study: The Trump administration’s Advisory Committee on Immunization Practices voted in December to abandon a 30-year recommendation that all babies born in the U.S. be vaccinated for hepatitis B at birth.

Source https://retractionwatch.com/2026/02/10/guest-post-cdc-hepatitis-b-study-ethics-must-never-be-published/

Another high-profile case has interested scientists. Read now